Acceptance rate:
Time to first decision:
6 days*
Time to first decision with review:
46 days*
Impact Factor (JCR):
Impact Factor rank (JCR):

Aims and scope

Journal of Medical Genetics is a leading international peer-reviewed journal covering original research in human genetics, including reviews of and opinion on the latest developments. Articles cover the molecular basis of human disease including germline cancer genetics, clinical manifestations of genetic disorders, applications of molecular genetics to medical practice and the systematic evaluation of such applications worldwide. For information about the Journal of Medical Genetics Editor-in-Chief Huw Dorkins and his editorial team, please refer to the Editorial Board page.

Transitioning to a greener future

From January 2023, Journal of Medical Genetics will publish solely online. This change brings significant climate and environmental benefits. Transitioning to online-only means we can completely eliminate the substantial use of energy, water and chemicals that is involved in the complex production and distribution process of a print journal. Most of our readers already use our website jmg.bmj.com for most of their needs, the website after all offers readers a far richer experience with more content overall. We hope that this change does not cause too much inconvenience for our readers as we move towards a greener future for Journal of Medical Genetics.

Plan S compliance

Journal of Medical Genetics is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and  Plan S compliance on our Author Hub.

Journal information

Journal of Medical Genetics is owned by BMJ. The journal has been adopted as the official journal of the Canadian College of Medical Geneticists
Publication Model
Subscription; with hybrid open access option
Launch date
Digital Archives
Indexed by
Web of Science Core Collection: Science Citation Index, Science Citation Index Extended; BIOSIS Previews, Current Contents: Clinical Medicine, Life Sciences; MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Print ISSN
Online ISSN

Journal Statistics 2023

Acceptance rate: 19%
Speed Time to first decision without review (median): 6 days Time to first decision with review (median): 46 days Time from acceptance to publication (median): 22 days
Impact Impact Factor category: Genetics & Heredity Impact Factor (JCR): 4 Impact Factor rank: 47/171 5 year Impact Factor: 4.9 Journal Citation Indicator (JCI): 1.3 Eigenfactor: 0.00943 Citescore: 9.6 Citescore rank: 10/90 Scimago Journal rank (SJR): 1.816
Reach Total content views: 456,890 Total Altmetric mentions: 1,246
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics

Contact information

For all contact information please refer to the contact us page.

For authors

Please refer to the Instructions for Authors.


Canadian College of Medical Geneticists logo
The Journal of Medical Genetics is an official journal of the Canadian College of Medical Geneticists.
COPE logo
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
Equator network logo
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. BMJ is a sponsor of its activities.
AllTrials logo
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.